title: Enzalutamide and sleep apnea: an emerging central nervous system side-effect?
authors.affiliation: Department of Medical Oncology, Institut Bergonié, Bordeaux.
authors.forename: F
authors.initials: F
authors.lastname: Labrize
authors.affiliation: Department of Medical Oncology, Clinique Francheville, Périgueux.
authors.forename: L
authors.initials: L
authors.lastname: Cany
authors.affiliation: Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif.
authors.forename: C
authors.initials: C
authors.lastname: Massard
authors.affiliation: Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif.
authors.forename: Y
authors.initials: Y
authors.lastname: Loriot
authors.affiliation: Department of Radiotherapy, Institut Bergonié, Bordeaux, France.
authors.forename: P
authors.initials: P
authors.lastname: Sargos
authors.affiliation: Department of Medical Oncology, Institut Bergonié, Bordeaux.
authors.forename: M
authors.initials: M
authors.lastname: Gross-Goupil
authors.affiliation: Department of Medical Oncology, Institut Bergonié, Bordeaux g.roubaud@bordeaux.unicancer.fr.
authors.forename: G
authors.initials: G
authors.lastname: Roubaud
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001549:Benzamides; D006801:Humans; D008297:Male; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy; D012891:Sleep Apnea Syndromes / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D009570:Nitriles; D010669:Phenylthiohydantoin; C540278:enzalutamide